Toxic effect of zinc on NF-κB, IL-2, IL-2 receptor α, and TNF-α in HUT-78 (Th0) cells

Toxicology Letters

Volumn 166, Issue 3, 2006, Pages 222-228

  Bao, Bin ^a   Prasad, Ananda ^a   Beck, Frances W J ^a   Suneja, Anupam ^a   Sarkar, Fazlul ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

High level of zinc; IL 2; IL 2R ; NF B; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; ZINC;

ARTICLE; CELL STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; TH1 CELL; ZINC BLOOD LEVEL;

BLOTTING, NORTHERN; CELL LINE; CELL NUCLEUS; CULTURE MEDIA; GENES, REPORTER; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LUCIFERASES; NF-KAPPA B; RECEPTORS, INTERLEUKIN-2; RNA, MESSENGER; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; ZINC;

EID: 33748932915     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2006.07.306     Document Type: Article

References (25)

1. Atasoy U., Curry S.L., Lopez de Silanes I., Shyu A.B., Casolaro V., Gorospe M., and Stellato C. Regulation of eotaxin gene expression by TNF-alpha and IL-4 through mRNA stabilization: involvement of the RNA-binding protein HuR. J. Immunol. 171 8 (2003) 4369-4378
2. Chandra R.K. Excessive intake of zinc impairs immune response. JAMA 525 (1984) 1443-1446
3. Erard F., Corthesy P., Smith K.A., Fiers W., Conzelmann A., and Nabholz M. Characterization of soluble factors that induce the cytolytic activity and the expression of T-cell growth factor receptors of a T-cell hybrid. J. Exp. Med. 160 (1980) 584-599
4. Fosmire G.J. Zinc toxicity. Am. J. Clin. Nutr. 51 (1978) 225-227
5. Gorospe M., Kumar S., and Baglioni C. Tumor necrosis factor increases stability of interleukin-1 mRNA by activating protein kinase C. J. Biol. Chem. 268 9 (1993) 6214-6220
6. Hatakeyama M., Tsudo M., Minamoto S., Kono T., Doi T., Miyata T., Miyasaka M., and Taniguchi T. Interleukin-2 receptor β chain gene: generation of three receptor forms by cloned human α and β chain cDNA's. Science 244 (1989) 551-556
7. Lowenthal J.W., Howe R.C., Ceredig R., and MacDonald H.R. Functional status of interleukin 2 receptors expressed by immature (Lyt-2-/L3T4-) thymocytes. J. Immunol. 137 (1984) 2579-2584
8. Oleske J.M., Westphal M.L., and Shore S. Zinc therapy of depressed cellular immunity in acrodermatitis enteropathica. Am. J. Dis. Child. 133 (1979) 915-918
9. Perkins N.D. Achieving transcriptional specificity with NF-kappa B. Int. J. Biochem. Cell. Biol. 29 (1997) 1433-1448
10. Porter A.G. Human tumour necrosis factors-α and -β: differences in their structure, expression and biological properties. FEMS. Microbiol. Immunol. 2 (1990) 193-199
11. Prasad A.S. Zinc in human health: an update. J. Trace Elemen. Experiment. Med. 11 (1998) 63-87
12. Prasad A., Bao B., Beck F.W., and Sarkar F.H. Zinc activates NF-κB in HUT 78 cells. J. Lab. Clin. Med. 138 (2001) 250-256
13. Prasad A., Bao B., and Beck F.W. Zinc enhances the expression of IL-2, IL-2 receptor α via NF-κB in HUT 78 cells. J. Lab. Clin. Med. 140 (2002) 272-289
14. Prasad A.S., Beck F.W., Endre L., Handschu W., Kukrga M., and Kumar G. Zinc deficiency affects cell cycle and deoxythymidine kinase gene expression in HUT-78 cells. J. Lab. Clin. Med. 128 (1996) 51-60
15. Prasad A.S., Brewer G.J., Schoomaker E.B., and Rabbani P. Hypocupremia induced by zinc therapy in adults. JAMA 240 (1978) 2166-2168
16. Prasad A.S., Meftah S., Abdallah J., Kaplan J., Brewer G.J., and Dardenne M. Serum thymulin in human zinc deficiency. J. Clin. Invest. 82 (1982) 1202-1210
17. Salvin S.B., Horecker B.L., Pan L.X., and Rabin B.S. The effect of dietary zinc and prothymosina on cellular immune responses of RF/J mice. Clin. Immunopathol. 43 (1987) 281-288
18. Sanceau J., Merlin G., and Wietzerbin J. Tumor necrosis factor-alpha and IL-6 up-regulate IFN-gamma receptor gene expression in human monocytic THP-1 cells by transcriptional and post-transcriptional mechanisms. J. Immunol. 149 5 (1992) 1671-1675
19. Seko Y., Cole S., Kasprzak W., Shapiro B.A., and Ragheb J.A. The role of cytokine mRNA stability in the pathogenesis of autoimmune disease. Autoimmun. Rev. 5 (2006) 299-305
20. Serfling E., Avots A., and Neumann M. The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activation. Biochim. Biophys. Acta 1263 (1995) 181-200
21. Siebenlist U., Franzoso G., and Brown K. Structure, regulation and function of NF-kappa B. Annu. Rev. Cell. Biol. 10 (1994) 405-455
22. Singh K.P., Zaidi S.I., Raisuddin S., Saxena A.K., Murthy R.C., and Ray P.K. Effect of zinc on immune functions and host resistance against infection and tumor challenge. Immunopharmacol. Immunotoxicol. 14 (1992) 813-840
23. Smith K.L., and Lawrence D.A. Immunomodulation of in vitro antigen presentation by cations. Toxicol. Appl. Pharmacol. 96 (1988) 476-484
24. Tanaka S., Akaishi E., Hosaka K., Okamura S., and Kubohara Y. Zinc ions suppress mitogen-activated interleukin-2 production in Jurkat cells. Biochem. Biophys. Res. Commun. 335 (2005) 162-167
25. Watts T.H. TNF/TNFR family members in costimulation of T-cell responses. Annu. Rev. Immunol. 23 (2005) 23-68